Free Trial Information
BioCentury | Mar 11, 2013
Clinical News

PST genetic test regulatory update

...Interleukin and dental benefits manager Renaissance Health Service Corp. (Indianapolis, Ind.) entered a 3-year preferred participation agreement under...
Read More
BioCentury | Mar 5, 2012
Financial News

C3 Jian completes venture financing

C3 Jian Inc. , Inglewood, Calif. Business: Infectious, Diagnostic Date completed: 2/27/12 Type: Venture financing Raised: $30 million Investors: Wyssta Investments; Renaissance Health Services; Corvesta Note: C3 Jian raised $30 million in a series C. The...
Read More
BioCentury | Feb 28, 2012
Financial News

C3 Jian raises $30 million

C3 Jian Inc. (Inglewood, Calif.) raised $30 million in a series C round from existing investors Wyssta Investments; Renaissance Health Services; and Corvesta. C3 Jian plans to submit an IND to FDA in April for...
Read More
Items per page:
1 - 3 of 3
BioCentury | Mar 11, 2013
Clinical News

PST genetic test regulatory update

...Interleukin and dental benefits manager Renaissance Health Service Corp. (Indianapolis, Ind.) entered a 3-year preferred participation agreement under...
Read More
BioCentury | Mar 5, 2012
Financial News

C3 Jian completes venture financing

C3 Jian Inc. , Inglewood, Calif. Business: Infectious, Diagnostic Date completed: 2/27/12 Type: Venture financing Raised: $30 million Investors: Wyssta Investments; Renaissance Health Services; Corvesta Note: C3 Jian raised $30 million in a series C. The...
Read More
BioCentury | Feb 28, 2012
Financial News

C3 Jian raises $30 million

C3 Jian Inc. (Inglewood, Calif.) raised $30 million in a series C round from existing investors Wyssta Investments; Renaissance Health Services; and Corvesta. C3 Jian plans to submit an IND to FDA in April for...
Read More
Items per page:
1 - 3 of 3